Similar articles

• HER2 Expression in NF1 Breast Cancer-Response.

  Wang X, Chitale D. Wang X, et al. Cancer Prev Res (Phila). 2019 Mar;12(3):197-198. doi: 10.1158/1940-6207.CAPR-18-0492. Epub 2019 Feb 21. Cancer Prev Res (Phila). 2019. PMID: 30792347 No abstract available.
• A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer.

  Güran S, Safali M. Güran S, et al. Cancer Genet Cytogenet. 2005 Jan 1;156(1):86-8. doi: 10.1016/j.cancergencyto.2004.04.019. Cancer Genet Cytogenet. 2005. PMID: 15588864
• A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.

  Esposito T, Piluso G, Saracino D, Uccello R, Schettino C, Dato C, Capaldo G, Giugliano T, Varriale B, Paolisso G, Di Iorio G, Melone MA. Esposito T, et al. J Neurochem. 2015 Dec;135(6):1123-8. doi: 10.1111/jnc.13396. Epub 2015 Nov 12. J Neurochem. 2015. PMID: 26478990
• Neurofibromatosis 1: closing the GAP between mice and men.

  Dasgupta B, Gutmann DH. Dasgupta B, et al. Curr Opin Genet Dev. 2003 Feb;13(1):20-7. doi: 10.1016/s0959-437x(02)00015-1. Curr Opin Genet Dev. 2003. PMID: 12573431 Review.
• A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.

  Ratner N, Miller SJ. Ratner N, et al. Nat Rev Cancer. 2015 May;15(5):290-301. doi: 10.1038/nrc3911. Epub 2015 Apr 16. Nat Rev Cancer. 2015. PMID: 25877329 Free PMC article. Review.